GSA Capital Partners’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Sell |
59,975
-12,174
| -17% | -$41K | 0.01% | 1503 |
|
|
2025
Q1 | $278K | Sell |
72,149
-46,179
| -39% | -$178K | 0.03% | 1205 |
|
|
2024
Q4 | $730K | Sell |
118,328
-55,416
| -32% | -$342K | 0.05% | 619 |
|
|
2024
Q3 | $935K | Sell |
173,744
-36,209
| -17% | -$195K | 0.07% | 511 |
|
|
2024
Q2 | $703K | Sell |
209,953
-6,394
| -3% | -$21.4K | 0.05% | 753 |
|
|
2024
Q1 | $872K | Buy |
216,347
+144,055
| +199% | +$581K | 0.07% | 533 |
|
|
2023
Q4 | $192K | Buy |
72,292
+28,711
| +66% | +$76.3K | 0.02% | 1331 |
|
|
2023
Q3 | $103K | Sell |
43,581
-194,619
| -82% | -$460K | 0.01% | 1383 |
|
|
2023
Q2 | $1.5M | Buy |
238,200
+140,300
| +143% | +$884K | 0.15% | 140 |
|
|
2023
Q1 | $565K | Buy |
97,900
+84,281
| +619% | +$486K | 0.06% | 630 |
|
|
2022
Q4 | $140K | Buy |
+13,619
| New | +$140K | 0.02% | 1259 |
|